BPM31510, a CoQ10-lipid nanoparticle, remodels the tumor microenvironment through immuno-metabolic reprogramming in syngeneic models

ubidecarenone IV (BPM31510 IV) - BPGbio

https://jitc.bmj.com/content/13/Suppl_2/A1357

Maria-Dorothea Nastke 1; Sylwia Stopka 2; Juan J Aristizabal-henao 3; Kaila M Bennett 4; Archna Ravi 5; Srada Karmacharya 6; Niven R Narain 7, 8; Michael A Kiebish 9; Stephane Gesta 10

Oct 3, 2025